CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 74 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $668,000 | -73.6% | 2,650 | -44.4% | 0.00% | -100.0% |
| Q1 2022 | $2,533,000 | -13.7% | 4,766 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,934,000 | -39.6% | 4,766 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $4,861,000 | -35.9% | 4,766 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $7,578,000 | -19.3% | 4,766 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $9,389,000 | +57.6% | 4,766 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $5,957,000 | -30.6% | 4,766 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $8,578,000 | -78.5% | 4,766 | 0.0% | 0.00% | -81.8% |
| Q2 2020 | $39,984,000 | +60.1% | 4,766 | 0.0% | 0.01% | +57.1% |
| Q1 2020 | $24,973,000 | -24.6% | 4,766 | 0.0% | 0.01% | +16.7% |
| Q4 2019 | $33,113,000 | -77.9% | 4,766 | -84.5% | 0.01% | -77.8% |
| Q3 2019 | $149,539,000 | -39.2% | 30,712 | -13.5% | 0.03% | -37.2% |
| Q2 2019 | $245,934,000 | – | 35,502 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 3,738,925 | $23,555,000 | 31.22% |
| Perceptive Advisors | 1,232,500 | $7,764,000 | 0.39% |
| IFP Advisors, Inc | 1,001,025 | $6,306,000 | 0.27% |
| WOODSTOCK CORP | 55,489 | $350,000 | 0.07% |
| Virtus ETF Advisers LLC | 50,795 | $320,000 | 0.05% |
| Dynamic Technology Lab Private Ltd | 31,431 | $198,000 | 0.04% |
| Evanson Asset Management, LLC | 20,660 | $130,000 | 0.03% |
| Artal Group S.A. | 250,000 | $1,575,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 58,800 | $370,000 | 0.02% |
| Raymond James Financial Services Advisors, Inc. | 426,280 | $2,686,000 | 0.02% |